GenAI-powered technology is set to reduce literature screening from days to mere hours. Watch our on-demand webinar to hear from industry professionals how automation is helping literature teams accelerate regulatory compliance, enhance scalability, and focus on high-value, strategic activities.
Don’t miss this opportunity to explore how you can revolutionize your approach to literature intake and assessment in just a few months – all without disrupting your existing PV IT environment.
"*" indicates required fields
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved